🇺🇸 FDA
Pipeline program

MB07133

H201110LC2

Phase 2 small_molecule active

Quick answer

MB07133 for Safety Issues is a Phase 2 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Safety Issues
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials